Ji YX - Search Results

1

The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy.

Liu J, Li W, Deng KQ, Tian S, Liu H, Shi H, Fang Q, Liu Z, Chen Z, Tian T, Gan S, Hu F, Hu M, Cheng X, Ji YX, Zhang P, She ZG, Zhang XJ, Chen S, Cai J, Li H. Liu J, et al. Among authors: ji yx. Circ Res. 2022 May 13;130(10):1586-1600. doi: 10.1161/CIRCRESAHA.121.318866. Epub 2022 Apr 19. Circ Res. 2022. PMID: 35437018 Free article.

2

Tripartite motif 32 prevents pathological cardiac hypertrophy.

Chen L, Huang J, Ji Y, Zhang X, Wang P, Deng K, Jiang X, Ma G, Li H. Chen L, et al. Clin Sci (Lond). 2016 May 1;130(10):813-28. doi: 10.1042/CS20150619. Epub 2016 Feb 16. Clin Sci (Lond). 2016. PMID: 26884348 Free PMC article.

3

Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.

Zhu X, Fang J, Gong J, Guo JH, Zhao GN, Ji YX, Liu HY, Wei X, Li H. Zhu X, et al. Among authors: ji yx. Hypertension. 2016 May;67(5):866-77. doi: 10.1161/HYPERTENSIONAHA.115.07042. Epub 2016 Mar 28. Hypertension. 2016. PMID: 27021007

4

Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.

Gao L, Wang PX, Zhang Y, Yu CJ, Ji Y, Wang X, Zhang P, Jiang X, Jin H, Huang Z, Zhang ZR, Li H. Gao L, et al. J Hepatol. 2016 Jul;65(1):125-136. doi: 10.1016/j.jhep.2016.03.006. Epub 2016 Mar 23. J Hepatol. 2016. PMID: 27032381

5

The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.

Ji YX, Zhang P, Zhang XJ, Zhao YC, Deng KQ, Jiang X, Wang PX, Huang Z, Li H. Ji YX, et al. Nat Commun. 2016 Jun 1;7:11267. doi: 10.1038/ncomms11267. Nat Commun. 2016. PMID: 27249171 Free PMC article.

6

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.

Deng KQ, Wang A, Ji YX, Zhang XJ, Fang J, Zhang Y, Zhang P, Jiang X, Gao L, Zhu XY, Zhao Y, Gao L, Yang Q, Zhu XH, Wei X, Pu J, Li H. Deng KQ, et al. Among authors: ji yx. Nat Commun. 2016 Jun 1;7:11432. doi: 10.1038/ncomms11432. Nat Commun. 2016. PMID: 27249321 Free PMC article.

7

The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.

Wang Z, Zhang XJ, Ji YX, Zhang P, Deng KQ, Gong J, Ren S, Wang X, Chen I, Wang H, Gao C, Yokota T, Ang YS, Li S, Cass A, Vondriska TM, Li G, Deb A, Srivastava D, Yang HT, Xiao X, Li H, Wang Y. Wang Z, et al. Among authors: ji yx. Nat Med. 2016 Oct;22(10):1131-1139. doi: 10.1038/nm.4179. Epub 2016 Sep 12. Nat Med. 2016. PMID: 27618650 Free PMC article.

8

Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β-Activated Kinase 1-Dependent Signaling Pathways.

Chen L, Huang J, Ji YX, Mei F, Wang PX, Deng KQ, Jiang X, Ma G, Li H. Chen L, et al. Among authors: ji yx. Hypertension. 2017 Feb;69(2):249-258. doi: 10.1161/HYPERTENSIONAHA.116.07741. Epub 2016 Dec 12. Hypertension. 2017. PMID: 27956576

9

The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis.

Yan FJ, Zhang XJ, Wang WX, Ji YX, Wang PX, Yang Y, Gong J, Shen LJ, Zhu XY, Huang Z, Li H. Yan FJ, et al. Among authors: ji yx. Hepatology. 2017 May;65(5):1492-1511. doi: 10.1002/hep.28971. Epub 2017 Mar 22. Hepatology. 2017. PMID: 27981609

10

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.

Wang PX, Ji YX, Zhang XJ, Zhao LP, Yan ZZ, Zhang P, Shen LJ, Yang X, Fang J, Tian S, Zhu XY, Gong J, Zhang X, Wei QF, Wang Y, Li J, Wan L, Xie Q, She ZG, Wang Z, Huang Z, Li H. Wang PX, et al. Among authors: ji yx. Nat Med. 2017 Apr;23(4):439-449. doi: 10.1038/nm.4290. Epub 2017 Feb 20. Nat Med. 2017. PMID: 28218919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page